Leidos Wins R&D Contract To Combat Weapons Of Mass Destruction

Leidos has been awarded a prime contract by the U.S. Defense Threat Reduction Agency (DTRA) to conduct research and development to combat weapons of mass destruction.

The multiple-award indefinite delivery/indefinite quantity (ID/IQ) contract has a five-year base period of performance, a five year option, and a total value of approximately $4 billion for all awardees, if all options are exercised. The contract was awarded under the Combating Weapons of Mass Destruction Research and Technology Development ID/IQ contract.

DTRA is the U.S. Department of Defense's Combat Support Agency for countering weapons of mass destruction. The agency's experts address the entire spectrum of chemical, biological, radiological, nuclear and high yield explosive threats.

Under the contract, Leidos will perform research and technology development to provide scientific and technological solutions to meet the DoD's non-proliferation, counterproliferation, and consequence management objectives. Leidos is one of seven contractors eligible to compete for task orders under the contract.

"Leidos is proud to provide continued support of the mission of the Defense Threat Reduction Agency to safeguard our nation and develop technologies to defeat weapons of mass destruction," said John Fratamico, Leidos group president.